Expansion of clinical genetic testing since the completion of the human genome project

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

The sequencing of the first human genome led to expectations of the widespread use of genetics in medicine. However, assessing the true impact of genetic testing on clinical practice is challenging due to the lack of integration in the electronic health record (EHR). We extracted clinical genetic tests from the EHRs of over 1.8 million patients seen at Vanderbilt University Medical Center from 2002 to 2022, using both automated and manual methods. Using these data, we quantified the extent of clinical genetic testing in healthcare and described how testing patterns have changed over time, including utilization rate, test comprehensiveness, diagnoses made, and the number of variants of uncertain significance (VUS) returned.

We also assessed genetic testing rates across medical specialties and introduce a measure – the genetic attributed fraction (GAF) – to compute the proportion of observed phenotypes attributable to a genetic diagnosis. We identified 104,392 tests, 32% of which were only reported in unstructured text, and 19,032 molecularly confirmed diagnoses or risk factors. The proportion of patients genetic testing recorded in their EHRs from 1.0% in 2002 to 6.1% in 2022, and testing became more comprehensive with the growing use of multigene panels. This corresponded with a substantial increase in the variety of diseases diagnosed with genetic testing, from 51 unique diseases in 2002 to 509 in 2022, alongside a growing number of VUS.

The phenome-wide GAF for 6,505,620 diagnoses made in 2022 was 0.46%, with 74 phenotypes having a GAF greater than 5%, including pancreatic insufficiency (67%), chorea (64%), atrial septal defect (24%), Microcephaly (17%), paraganglioma (17%), and ovarian cancer (6.8%). Our study provides a comprehensive quantification of the increasing role of genetic testing at a major academic medical institution. These results demonstrate the now pervasive use of genetic testing across diverse medical contexts and its growing utility in explaining observed medical phenome.

Article activity feed